department of neurology  
  neuro-icu header  
  Telephone: 212 305-7236 || Address: The Neurological Institute of New York, 710 West 168th Street, 6th Floor, New York, NY 10032  


Clinical trials are essential for evaluating the effectiveness of new diagnostic tests and treatments which might improve outcome. At the Columbia Neuro-ICU, the following clinical research protocols are either in progress or in the planning stages:


Acetazolamide-Activated SPECT for Presymptomatic Detection of Ischemia from Vasospasm after Subarachnoid Hemorrhage (SAH)
Cognitive Dysfunction and Quality of Life after Subarachnoid Hemorrhage (SAH)
Endovascular GDC Coil Treatment for Poor Grade, High Risk patients with Subarachnoid Hemorrhage (SAH)
Intraventricular Urokinase for Intraventricular Hemorrhage (IVH)
Non-invasive Ultrasound for Intracranial Pressure (ICP) Monitoring
"Play the Winner" Clinical Trial of Endovascular Therapy for Refractory Vasospasm after Subarachnoid Hemorrhage (SAH)
Propofol for Sedation in Critically-Ill Neurologic Patients
Systemic hypothermia for acute cerebral infarction


About the Division of Neurocritical Care || What is Neurocritical || Our Doctors || Patient Information || Diseases and Conditions || Neuro-ICU Monitoring and Treatment || Events || Resources || Education || Research || Contact Us || Sitemap
Copyright © 2008 Division of Neurocritical Care, Department of Neurology, Columbia University Medical Center, New York || The Neurological Institute of New York
Affiliated with New York-Presbyterian Hospital || Last updated: August 27, 2014 |